These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
311 related articles for article (PubMed ID: 12742806)
1. Relation of triglyceride levels, fasting and nonfasting, to fatal and nonfatal coronary heart disease. Eberly LE; Stamler J; Neaton JD; Arch Intern Med; 2003 May; 163(9):1077-83. PubMed ID: 12742806 [TBL] [Abstract][Full Text] [Related]
2. Triglycerides + high-density-lipoprotein-cholesterol dyslipidaemia, a coronary risk factor in elderly women: the CArdiovascular STudy in the ELderly. Mazza A; Tikhonoff V; Schiavon L; Casiglia E Intern Med J; 2005 Oct; 35(10):604-10. PubMed ID: 16207260 [TBL] [Abstract][Full Text] [Related]
3. Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women. Bansal S; Buring JE; Rifai N; Mora S; Sacks FM; Ridker PM JAMA; 2007 Jul; 298(3):309-16. PubMed ID: 17635891 [TBL] [Abstract][Full Text] [Related]
4. A long-term follow-up study of serum lipid levels and coronary heart disease in the elderly. Li JZ; Chen ML; Wang S; Dong J; Zeng P; Hou LW Chin Med J (Engl); 2004 Feb; 117(2):163-7. PubMed ID: 14975195 [TBL] [Abstract][Full Text] [Related]
5. High attributable risk of elevated C-reactive protein level to conventional coronary heart disease risk factors: the Third National Health and Nutrition Examination Survey. Miller M; Zhan M; Havas S Arch Intern Med; 2005 Oct; 165(18):2063-8. PubMed ID: 16216995 [TBL] [Abstract][Full Text] [Related]
6. Fasting and nonfasting lipid levels: influence of normal food intake on lipids, lipoproteins, apolipoproteins, and cardiovascular risk prediction. Langsted A; Freiberg JJ; Nordestgaard BG Circulation; 2008 Nov; 118(20):2047-56. PubMed ID: 18955664 [TBL] [Abstract][Full Text] [Related]
7. Heterozygote men with familial hypercholesterolaemia may have an abnormal triglyceride response post-prandially. Evidence for another predictor of vascular risk in familial hypercholesterolaemia. Kolovou GD; Anagnostopoulou KK; Pilatis ND; Iraklianou S; Hoursalas IS; Liberi S; Pavlidis AN; Dritsas A; Mikhailidis DP; Cokkinos DV Int J Clin Pract; 2005 Mar; 59(3):311-7. PubMed ID: 15857328 [TBL] [Abstract][Full Text] [Related]
8. Triglyceride predicts cardiovascular mortality and its relationship with glycaemia and obesity in Chinese type 2 diabetic patients. Chan WB; Tong PC; Chow CC; So WY; Ng MC; Ma RC; Osaki R; Cockram CS; Chan JC Diabetes Metab Res Rev; 2005; 21(2):183-8. PubMed ID: 15386811 [TBL] [Abstract][Full Text] [Related]
9. Hepatic fat content is a determinant of postprandial triglyceride levels in type 2 diabetes mellitus patients with normal fasting triglyceride. Nimitphong H; Phongkitkarun S; Rattarasarn C; Kongsooksai A; Chanprasertyothin S; Bunnag PA; Puavilai G Metabolism; 2008 May; 57(5):644-9. PubMed ID: 18442627 [TBL] [Abstract][Full Text] [Related]
10. Comparison of the 1997 and 2003 American Diabetes Association classification of impaired fasting glucose: impact on prevalence of impaired fasting glucose, coronary heart disease risk factors, and coronary heart disease in a community-based medical practice. Kim SH; Chunawala L; Linde R; Reaven GM J Am Coll Cardiol; 2006 Jul; 48(2):293-7. PubMed ID: 16843178 [TBL] [Abstract][Full Text] [Related]
12. The association of fasting glucose levels with congestive heart failure in diabetic adults > or =65 years: the Cardiovascular Health Study. Barzilay JI; Kronmal RA; Gottdiener JS; Smith NL; Burke GL; Tracy R; Savage PJ; Carlson M J Am Coll Cardiol; 2004 Jun; 43(12):2236-41. PubMed ID: 15193686 [TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety profile of fenofibrate-coated microgranules 130 mg, with and without food, in patients with hypertriglyceridemia and the metabolic syndrome: an 8-week, randomized, double-blind, placebo-controlled study. Davidson MH; Bays H; Rhyne J; Stein E; Rotenberg K; Doyle R Clin Ther; 2005 Jun; 27(6):715-27. PubMed ID: 16117978 [TBL] [Abstract][Full Text] [Related]
14. Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women. Nordestgaard BG; Benn M; Schnohr P; Tybjaerg-Hansen A JAMA; 2007 Jul; 298(3):299-308. PubMed ID: 17635890 [TBL] [Abstract][Full Text] [Related]
15. Xuezhikang, an extract of cholestin, protects endothelial function through antiinflammatory and lipid-lowering mechanisms in patients with coronary heart disease. Zhao SP; Liu L; Cheng YC; Shishehbor MH; Liu MH; Peng DQ; Li YL Circulation; 2004 Aug; 110(8):915-20. PubMed ID: 15313947 [TBL] [Abstract][Full Text] [Related]
16. Impact of impaired fasting glucose on cardiovascular disease: the Framingham Heart Study. Levitzky YS; Pencina MJ; D'Agostino RB; Meigs JB; Murabito JM; Vasan RS; Fox CS J Am Coll Cardiol; 2008 Jan; 51(3):264-70. PubMed ID: 18206734 [TBL] [Abstract][Full Text] [Related]
18. Triglycerides and coronary risk in women and the elderly. LaRosa JC Arch Intern Med; 1997 May; 157(9):961-8. PubMed ID: 9140266 [TBL] [Abstract][Full Text] [Related]
19. Plasma triglycerides, an independent predictor of cardiovascular disease in men: a prospective study based on a population with prevalent metabolic syndrome. Onat A; Sari I; Yazici M; Can G; Hergenç G; Avci GS Int J Cardiol; 2006 Mar; 108(1):89-95. PubMed ID: 16085325 [TBL] [Abstract][Full Text] [Related]
20. Is hypertriglyceridaemia an independent risk factor for coronary heart disease? The epidemiological evidence. Miller M Eur Heart J; 1998 Jul; 19 Suppl H():H18-22. PubMed ID: 9717060 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]